Current status and future prospects in the search for protein biomarkers of immunosenescence

Expert Review of Proteomics

Volumn 5, Issue 4, 2008, Pages 561-569

  Wilson, Steve ^a   Mazzatti, Dawn J ^a  

^a UNILEVER RESEARCH   (United Kingdom)

Author keywords

2D gel electrophoresis; Aging; Biomarker; DIGE; Immunosenescence; Multiplex; Post translational modification; Proteomics; SELDI; Surface enhanced laser desorption ionization

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE;

AGING; ALZHEIMER DISEASE; ANTIBODY LABELING; ATHEROSCLEROSIS; FLUORESCENCE; GLYCATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNE SYSTEM; IMMUNITY; MASS SPECTROMETRY; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEOMICS; REVIEW; TWO DIMENSIONAL ELECTROPHORESIS;

AGING; ANIMALS; BIOLOGICAL MARKERS; FORECASTING; HUMANS; PROTEINS; PROTEOMICS;

EID: 51149116750     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/14789450.5.4.561     Document Type: Review

References (59)

1. Gruver AL, Hudson LL, Sempowski GD. Immunosenescence of ageing. J. Pathol. 211(2), 144-156 (2007).
2. Pawelec G, Akbar A, Caruso C, Solana R, Grubeck-Loebenstein B, Wikby A. Human immunosenescence: is it infectious? Immunol. Rev. 205, 257-268 (2005).
3. Larbi A, Franceschi C, Mazzatti D, Solana R, Wikby A, Pawelec G. Aging of the immune system as a prognostic factor for human longevity. Physiology (Bethesda) 23, 64-74 (2008).
4. Cimmino F, Spano D, Capasso M et al. Comparative proteomic expression profile in all-trans retinoic acid differentiated neuroblastoma cell line. J. Proteome Res. 6(7), 2550-2564 (2007).
5. Murphy L, Clynes M, Keenan J. Proteomic analysis to dissect mitoxantrone resistance-associated proteins in a squamous lung carcinoma. Anticancer Res. 27(3A), 1277-1284 (2007).
6. Gez S, Crossett B, Christopherson RI. Differentially expressed cytosolic proteins in human leukemia and lymphoma cell lines correlate with lineages and functions. Biochim. Biophys. Acta. 1774(9), 1173-1183 (2007).
7. Kolkman A, Dirksen EH, Slijper M, Heck AJ. Double standards in quantitative proteomics: direct comparative assessment of difference in gel electrophoresis and metabolic stable isotope labeling. Mol. Cell. Proteomics 4(3), 255-266 (2005). •• Provides a comparative assessment of DIGE and metabolic stable-isotope labeling, showing high levels of correlation between the two methods.
8. D'Hertog W, Overbergh L, Lage K et al. Proteomics analysis of cytokine-induced dysfunction and death in insulin-producing INS-1E cells: new insights into the pathways involved. Mol. Cell. Proteomics 6(12), 2180-2199 (2007).
9. Hoorn EJ, Hoffert JD, Knepper MA. The application of DIGE-based proteomics to renal physiology. Nephron. Physiol. 104(1), 61-72 (2006).
10. Hutchens TW, Yip TT. New desorption strategies for the mass spectrometric analysis of macromolecules. Rapid Commun. Mass Spectrom. 7, 576-580 (2003).
11. Paweletz CP, Trock B, Pennanen M et al. Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer. Dis. Markers 17(4), 301-307 (2001).
12. Srinivas PR, Srivastava S, Hanash S, Wright GL Jr. Proteomics in early detection of cancer. Clin. Chem. 47(10), 1901-1911 (2001).
13. Ranganathan S, Williams E, Ganchev P et al. Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis. J. Neurochem. 95(5), 1461-1471 (2005).
14. Mazzatti DJ, Pawelec G, Longdin R, Powell JR, Forsey RJ. SELDI-TOF-MS ProteinChip array profiling of T-cell clones propagated in long-term culture identifies human profilin-1 as a potential bio-marker of immunosenescence. Proteome Sci. 5, 7 (2007).
15. Koopmann J, Zhang Z, White N et al. Serum diagnostics of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionisation mass spectrometry. Clin. Cancer Res. 10, 860-868 (2004). •• Demonstrates that SELDI profiling of serum can be used to accurately differentiate patients with cancer from those with other diseases and from healthy controls.
16. Wikby A, Johansson B, Ferguson F et al. Age-related changes in immune parameters in a very old population of Swedish people: a longitudinal study. Exp. Geront. 29(5), 531-541 (1994).
17. Pawelec G, Ferguson FG, Wikby A. The SENIEUR protocol after 16 years. Mech. Ageing Dev. 122(2), 132-134 (2001).
18. Ball G, Mian S, Holding F et al. An integrated approach utilizing artificial neural networks and SELDI mass spectrometry for the classification of human tumours and rapid identification of potential biomarkers. Bioinformatics 18(3), 395-404 (2002).
19. Gokulrangan G, Zaidi A, Michaelis ML, Schöneich C. Proteomic analysis of protein nitration in rat cerebellum: effect of biological aging. J. Neurochem. 100(6), 1494-1504 (2007). • Describes a novel proteomic approach to identify cerebellar protein targets for nitration.
20. Oliver CN, Ahn BW, Moerman EJ, Goldstein S, Stadtman ER. Age-related changes in oxidized proteins. J. Biol. Chem. 262(12), 5488-5491 (1981).
21. Stadtman ER, Starke-Reed PE, Oliver CN, Carney JM, Floyd RA. Protein modification in aging. EXS 62, 64-72 (1992).
22. Beal MF. Oxidatively modified proteins in aging and disease. Free Radic. Biol. Med. 32(9), 797-803 (2002).
23. Hensley K, Hall N, Subramaniam R et al. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J. Neurochem. 65(5), 2146-2156 (1995).
24. Shaw PJ, Ince PG, Falkous G, Mantle D. Oxidative damage to protein in sporadic motor neuron disease spinal cord. Ann. Neurol. 38(4), 691-695 (1995).
25. Castegna A, Aksenov M, Thongboonkerd V et al. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, α-enolase and heat shock cognate 71. J. Neurochem. 82(6), 1524-1532 (2002).
26. Castegna A, Aksenov M, Aksenova M et al. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radic. Biol. Med. 33(4), 562-571 (2002).
27. Kim HJ, Barajas B, Chan RC, Nel AE. Glutathione depletion inhibits dendritic cell maturation and delayed-type hypersensitivity: implications for systemic disease and immunosenescence. J. Allergy Clin. Immunol. 119(5), 1225-1233 (2007).
28. Gringhuis SI, Papendrecht-van der Voort EA, Leow A, Nivine Levarht EW, Breedveld FC, Verweij CL. Effect of redox balance alterations on cellular localization of LAT and downstream T-cell receptor signaling pathways. Mol. Cell. Biol. 22(2), 400-411 (2002).
29. Nindl G, Peterson NR, Hughes EF, Waite LR, Johnson MT. Effect of hydrogen peroxide on proliferation, apoptosis and interleukin-2 production of Jurkat T cells. Biomed. Sci. Instrum. 40, 123-128 (2004).
30. Sharov VS, Schöneich C. Proteomic approach to aging research. Expert Rev. Proteomics 4(2), 309-321 (2007).
31. Tyther R, Ahmeda A, Johns E, Sheehan D. Proteomic identification of tyrosine nitration targets in kidney of spontaneously hypertensive rats. Proteomics 7(24), 4555-4564 (2007).
32. Fukami K, Yamagishi S, Ueda S, Okuda S. Role of AGEs in diabetic nephropathy. Curr. Pharm. Des. 14(10), 946-952 (2008).
33. Grillo MA, Colombatto S. Advanced glycation end-products (AGEs): involvement in aging and in neurodegenerative diseases. Amino Acids 35(1), 29-36 (2008).
34. Vlassara H, Uribarri J. Glycoxidation and diabetic complications: modern lessons and a warning? Rev. Endocr. Metab. Disord. 5(3), 181-188 (2004).
35. Zhang Y, Cocklin RR, Bidasee KR, Wang M. Rapid determination of advanced glycation end products of proteins using MALDI-TOF-MS and PERL script peptide searching algorithm. J. Biomol. Tech. 14(3), 224-230 (2003). •• Applies an in-house developed PERL script algorithm (http://proteomics. biochemistry.iu.edu) to detect post-translational modifications coupled with MALDI-TOF-mass spectrometry (MS).
36. Sen CK, Packer L. Antioxidant and redox regulation of gene transcription. FASEB J. 10(7), 709-720 (1996).
37. Cemerski S, Cantagrel A, Van Meerwijk JP, Romagnoli P. Reactive oxygen species differentially affect T cell receptor-signaling pathways. J. Biol. Chem. 277(22), 19585-19593 (2002).
38. Pawelec G, Hirokawa K, Fülöp T. Altered T cell signalling in ageing. Mech. Ageing Dev. 122(14), 1613-1637 (2001).
39. Nakamura M, Yamada M, Ohsawa T et al. Phosphoproteomic profiling of human SH-SY5Y neuroblastoma cells during response to 6-hydroxydopamine- induced oxidative stress. Biochim. Biophys. Acta. 1763(9), 977-989 (2006). • Examines changes in whole proteins and phosphoproteins under oxidative stress.
40. MacCoss MJ, McDonald WH, Saraf A et al. Shotgun identification of protein modifications from protein complexes and lens tissue. Proc. Natl Acad. Sci. USA 99(12), 7900-7905 (2002).
41. Sanchez-Carbayo M. Antibody arrays: technical considerations and clinical applications in cancer. Clin. Chem. 52(9), 1651-1659 (2006).
42. Armstrong L, Hughes O, Yung S et al. The role of PI3K/AKT, MAPK/ERK and NFκβ signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis. Hum. Mol. Genet. 15(11), 1894-1913 (2006).
43. Moschos SJ, Smith AP, Mandic M et al. SAGE and antibody array analysis of melanoma-infiltrated lymph nodes: identification of Ubc9 as an important molecule in advanced-stage melanomas. Oncogene 26(29), 4216-4225 (2007).
44. Ramakers JD, Mensink RP, Schaart G, Plat J. Arachidonic acid but not eicosapentaenoic acid (EPA) and oleic acid activates NF-κB and elevates ICAM-1 expression in Caco-2 cells. Lipids 42(8), 687-698 (2007).
45. Kopf E, Zharhary D. Antibody arrays - an emerging tool in cancer proteomics. Int. J. Biochem. Cell. Biol. 39(7-8), 1305-1317 (2007).
46. Falkensammer C, Jöhrer K, Gander H et al. IL-4 inhibits the TNF-α induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-α to induce apoptotic and cytokine responses by RCC: implications for antitumor immune responses. Cancer Immunol. Immunother. 55(10), 1228-1237 (2006).
47. Pike LJ. Lipid rafts: heterogeneity on the high seas. Biochem. J. 378(Pt 2), 281-292 (2004).
48. + human T lymphocytes with aging. Cell Signal. 18(7), 1017-1030 (2006).
49. Larbi A, Douziech N, Khalil A et al. Effects of methyl-β-cyclodextrin on T lymphocytes lipid rafts with aging. Exp. Gerontol. 39(4), 551-558 (2004).
50. Yanagida M, Nakayama H, Yoshizaki F et al. Proteomic analysis of plasma membrane lipid rafts of HL-60 cells. Proteomics 7(14), 2398-2409 (2007). α Investigates the changes in protein composition of plasma membrane lipid rafts by nano-liquid chromatography-MS/MS analysis and stable isotope labeling.
51. Harris TB, Ferrucci L, Tracy RP et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am. J. Med. 106, 506-512 (1999).
52. Ershler WB, Keller ET. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Ann. Rev. Med. 51, 245-270 (2000).
53. Ferrucci L, Harris TB, Guralnik JM et al. Serum IL-6 level and the development of disability in older persons. J. Am. Geriatr. Soc. 47(6), 639-646 (1999).
54. Bruunsgard H, Ladelund S, Pederson AN et al. Predicting death from tumour necrosis factor-α and interleukin-6 in 80-year-old people. Clin. Exp. Immunol. 132, 24-31 (2003).
55. Franceschi C, Bonafè M, Valensin S et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. NY Acad. Sci. 908, 244-254 (2000).
56. Forsey RJ, Thompson JM, Ernerudh J et al. Plasma cytokine profiles in elderly humans. Mech. Ageing Dev. 124(4), 487-493 (2003).
57. Puts MT, Visser M, Twisk JW, Deeg DJ, Lips P. Endocrine and inflammatory markers as predictors of frailty. Clin. Endocrinol. (Oxf.) 63(4), 403-411 (2005).
58. Franceschi C, Valensin S, Fagnoni F, Barbi C, Bonafè M. Biomarkers of immunosenescence within an evolutionary perspective: the challenge of heterogeneity and the role of antigenic load. Exp. Gerontol. 34(8), 911-921 (1999).
59. R&D Systems - Tools for Cell Biology Research www.rndsystems.com